Danish marijuana companies attracted $217 million in funding, report finds

Medical marijuana companies in Denmark attracted external capital of more than 1.5 billion Danish krone ($217 million), including founders’ own investments, which works out to an average of $6 million per business.

Denmark medical cannabis sales post a positive quarter thanks to Epidiolex

Sales of medical marijuana in Denmark posted healthy gains in the third quarter of 2020, coinciding with the launch of GW Pharmaceuticals’ cannabis drug Epidiolex.